You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Mallinckrodt
Medtronic
Colorcon
Baxter

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for SHR-1210

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug SHR-1210?

SHR-1210 is an investigational drug.

There have been 159 clinical trials for SHR-1210. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2012.

The most common disease conditions in clinical trials are Carcinoma, Lung Neoplasms, and Neoplasms. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Atridia Pty Ltd., and Sun Yat-sen University.

There are five US patents protecting this investigational drug and thirty international patents.

Recent Clinical Trials for SHR-1210
TitleSponsorPhase
A Trial of SHR-1905 in Healthy SubjectsAtridia Pty Ltd.Phase 1
Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque PsoriasisJiangsu HengRui Medicine Co., Ltd.Phase 3
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/Phase 2

See all SHR-1210 clinical trials

Clinical Trial Summary for SHR-1210

Top disease conditions for SHR-1210
Top clinical trial sponsors for SHR-1210

See all SHR-1210 clinical trials

US Patents for SHR-1210

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SHR-1210   Start Trial Method of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA)   Start Trial
SHR-1210   Start Trial Combination therapies of HDAC inhibitors and PD-1 inhibitors HUYA Bioscience International, LLC (San Diego, CA)   Start Trial
SHR-1210   Start Trial Methods of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Mallinckrodt
Medtronic
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.